Therapeutic Hypothermia
Since December 2005, our hospital has been using hypothermia therapy according to the American Heart Association (AHA) Guidelines, if the patients' family provided permission to do so. Thereafter, all patients received hypothermia therapy; 25 consecutive patients received hypothermia therapy, while 21 did not because they were treated prior to 2005 .
As soon as a patient was brought in our emergency center, 1,000 ml of saline at 4°C was intravenously infused at a rate of 400 ml/h, followed by an injection of cold water through a stomach tube. Patients were wrapped in a cold blanket, maintained at 34°C for 24 h, and sedated by continuous midazolam infusion. Vecuronium bromide was administered to avoid shivering during hypothermia. After 24 h, the patient was re-warmed at a rate of 0.5°C every 6 h.
Patient Management
All patients were intubated and mechanically ventilated in the ICU. Central venous lines and urine catheters were inserted. Patients received routine acute clinical care, including electrocardiographic and echocardiograpic monitoring, and blood exams. A coronary angiography was performed if a ST-segment elevation was observed on an electrocardiogram. Antiplatelet drugs were administered when coronary intervention was performed. The need for fluid infusion was assessed using respiratory variation in the inferior vena cava diameter. 12 
Statistical Analysis
Continuous data are presented as mean ± SD, and the categorical data are presented using absolute frequencies. The comparison between continuous variables was performed using the Student's t-test and categorical data was compared using the chi-squared test. Multilogistic regression analysis was used to identify the independent predictors of neurological recovery after ROSC. A P value of less than 0.05 was considered statistically significant. All statistical analyses were performed using a statistical software program (SPSS for Windows, version 11.5, SPSS Inc, Chicago, IL, USA).
Results
Forty-six comatose patients, who suffered an out-of-hospital cardiac arrest, were consecutively enrolled in the present study. Consequently, 28 patients recovered to CPC class 1 or 2. As shown in Table 1 , the time from collapse to spontaneous circulation was 11.9±8.8 min in the neurological recovery group and 16.4±7.8 min in the non-recovery group; this was not significantly different (P=0.09). The rates of performance of bystander CPR (P=0.370) and witnessed collapse (P=0.067) were not different between the 2 groups. The presence of a light reflex, acute coronary syndrome (ACS), and performance of hypothermia therapy were significant. Percutaneous coronary intervention for ACS was successfully conducted to achieve reperfusion in all patients (all patients had a TIMI grade 2 or 3). On the multilogistic regression analysis, the additional hypothermia therapy was an independent predictor of neurological recovery (P=0.005, OR 6.5, 95%CI 1.74-24.27; Table 2 ). Eight out of 21 patients (38%) recovered before hypothermia therapy was considered, and 20 out of 25 patients (80%) recovered after receiving hypothermia therapy. This improvement rate of neurological prognosis was statistically significant (P=0.004).
Active bleeding or intra-cranial hemorrhage did not occur during hypothermia therapy. One patient had a recurrence of VF during hypothermia. He recovered to sinus rhythm with the help of a defibrillator and was discharged without any deficiency.
Among the factors examined, base excess was significantly higher and pH was significantly higher in patients who subsequently recovered following hypothermia therapy ( Table 3 ). The level of brain natriuretic peptide did not significantly differ between the 2 groups (P=0.413). Also, there were no significant differences in peak creatine kinase (CK), peak CK muscle/brain isozyme, or ejection fraction between the recovery and non-recovery groups after hypothermia therapy.
Discussion
There are 3 phases of cerebral injury after brain hypoxia caused by cardiac arrest, and hypothermia therapy is considered to be neuroprotective at each of these stages. 14, 15 Cardiac arrest stops cerebral blood flow despite ongoing consumption of oxygen, adenosine triphosphate, and glucose. In the first stage, hypothermia decreases energy utilization and consumption of oxygen and glucose. [16] [17] [18] [19] Thereafter, excitatory amino acids and glutamate are released from the brain, which activate cytotoxic free radicals and nitric oxide. 16 Hypothermia decreases the release of such excitatory amino acids and other neurotoxic mediators, 17, [20] [21] [22] [23] [24] reduces nitric oxide production, and delays the peak level of nitric oxide. 14, 21, 25 The late phase of cerebral injury occurs up to 24 h after cardiac arrest. At this stage, the blood-brain barrier breaks down, cerebral edema worsens, and seizures and neuron death might occur. 16 Hypothermia therapy slows the deterioration of the blood-brain barrier and decreases cerebral edema. 14, 16, 26 The AHA guidelines recommend hypothermia therapy for comatose patients with VF, which is classified as class 2a. But there have been no reports on the effects of hypothermia therapy on Japanese comatose patients. The time from collapse to spontaneous circulation observed in this study was shorter than that reported in previous randomized studies. 5, 6 Even though there was no statistically significant difference in the time to spontaneous circulation between the recovery and non-recovery groups, this short time might contribute to improving prognosis in those patients receiving hypothermia therapy. Therefore, we should keep making an effort to shorten the time from VF to resuscitation, and to make patients start having spontaneous circulation as soon as possible.
In our facility, hypothermia therapy was introduced in 2005. Furthermore, in 2005, the resuscitation protocol was revised, and the resuscitation procedures in this study were changed as follows. The ratio of sternal compression and artificial respiration was improved from 15:2 to 30:2 to minimize interruption of cardiac massage. When there was no witness, the emergency crew treatment was changed from "shock first" to "CPR first". Defibrillation energy was set at 360 J from the beginning. In addition, intravenous Amiodaron was available in Japan since 2007. These improvements in the resuscitation protocol, as well as the introduction of hypothermia, might have a positive effect on neurological prognosis.
The patients receiving PCPS were excluded from our study, because the body was cooled for all patients who received mechanical support (PCPS) in our facility, even prior to 2005 when hypothermia therapy was introduced. In this study, we investigated the effect of hypothermia on improvement of neurological prognosis by comparing the resuscitation results before and after hypothermia introduction.
Nagao et al report that when a ROSC can not be achieved, the introduction of PCPS improved prognosis. 27 There might be a possibility that positive use of PCPS could improve prognosis, even in the patients who did not show a ROSC.
Neurological improvement after the introduction of hypothermia was more favorable in this study than in previous studies. The reasons for this were thought to be as follows: in randomized studies conducted by Bernard et al, 6 and The Hypothermia after Cardiac Arrest Study Group, 5 the mean time from collapse to ROSC in patients receiving hypothermia was 26.5 and 22 min, respectively. In our study, the mean time from collapse to ROSC was 11.9 min in the recovery group and 16.4 min in the non-recovery group, which was shorter than the results obtained from these two previous studies. This might be one of the factors to make neurological prognosis favorable in our study. Furthermore, the revision of the resuscitation protocol after publication of these randomized studies and the differences in the emergency medical system between Japan and Western countries could be the reasons for these differences. 28, 29 In addition, the ethnic difference in the effect of β-blockers in patients who have experienced cardiac failure has been reported. 30 More studies with Japanese patients is necessary in future.
In Japan, AED are placed in many places such as airports, schools and stations. 31 In addition, the medical control councils have been established regionally to prepare the resuscitation protocols. A lot of efforts are made to improve resuscitation treatments based on reflections obtained by reviewing different cases. Consequently, the time from collapse to ROSC in our region became shorter than that reported in previous randomized studies. We should continue to make an effort to shorten it more.
Despite recent guideline recommendations, the practical use of hypothermia therapy remains low in the USA and Europe. 10, 32 A 2005 survey conducted in the USA revealed that only 26% of physicians used the hypothermia therapy to treat comatose patients after resuscitation. The main reasons reported were lack of research data and concerns with technical difficulties of cooling methods. 33 In our hospital, we simply use cold water and a cooling mat.
The most important adverse events related to hypothermia are hypothermia-associated sepsis, coagulopathy, and cardiac arrhythmias. 5 In this study, the rate of adverse events associated with hypothermia was low, but to ensure prompt identification of complications, we conducted frequent blood examinations such as tests for blood count, international normalized ratio, partial thromboplastin time, and serum C-reactive protein levels. In the present study, only 1 patient suffered a recurrence of VF, and that patient was treated with defibrillation. Electrocardiogram monitoring is essential to discover VF recurrence as soon as possible, and frequent culturing of the septum and blood are necessary to determine the species of bacteria and its sensitivity to antibiotics.
The usefulness of pre-hospital hypothermia therapy has been reported, 34 and quick cooling to the target temperature is important. The use of a central cooling catheter, which is used widely in Europe and the USA, is prohibited in Japan. In future, these new equipments might help produce better results in Japanese patients who have experienced a cardiac arrest because of VF.
Study Limitations
One of the major limitations of this study was its non-randomized design. There are also questions regarding the practical duration of hypothermia and how quickly body temperature should be restored. Further studies are needed to establish more effective practical methods.
Conclusion
Hypothermia therapy is very useful for patients who experience an out-of-hospital cardiac arrest. Hypothermia should be induced rapidly and smoothly to achieve the best results in ROSC patients.
